HK1136962A1 - Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof - Google Patents

Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof

Info

Publication number
HK1136962A1
HK1136962A1 HK10100672.3A HK10100672A HK1136962A1 HK 1136962 A1 HK1136962 A1 HK 1136962A1 HK 10100672 A HK10100672 A HK 10100672A HK 1136962 A1 HK1136962 A1 HK 1136962A1
Authority
HK
Hong Kong
Prior art keywords
preparation
osmotic pump
controlled porosity
high permeable
pump tablet
Prior art date
Application number
HK10100672.3A
Other languages
English (en)
Inventor
Jingang Wang
Haisong Jiang
Original Assignee
Cosci Med Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosci Med Tech Co Ltd filed Critical Cosci Med Tech Co Ltd
Publication of HK1136962A1 publication Critical patent/HK1136962A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK10100672.3A 2006-10-16 2010-01-21 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof HK1136962A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200610140521A CN100584319C (zh) 2006-10-16 2006-10-16 群孔释放渗透泵控释片及其制备方法
PCT/CN2007/002967 WO2008052417A1 (fr) 2006-10-16 2007-10-16 Comprimé à pompe osmotique à porosité contrôlée de médicaments hautement perméables et procédé de préparation de celui-ci

Publications (1)

Publication Number Publication Date
HK1136962A1 true HK1136962A1 (en) 2010-07-16

Family

ID=37816128

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10100672.3A HK1136962A1 (en) 2006-10-16 2010-01-21 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof

Country Status (8)

Country Link
US (1) US8703193B2 (xx)
EP (2) EP2679220B1 (xx)
CN (1) CN100584319C (xx)
DK (2) DK2085078T3 (xx)
ES (2) ES2446267T3 (xx)
HK (1) HK1136962A1 (xx)
PL (2) PL2679220T3 (xx)
WO (1) WO2008052417A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100584319C (zh) * 2006-10-16 2010-01-27 北京科信必成医药科技发展有限公司 群孔释放渗透泵控释片及其制备方法
CN101642444B (zh) * 2008-08-08 2011-09-21 鲁南制药集团股份有限公司 单硝酸异山梨酯双速渗透泵型控释制剂及其制备方法
CN101642443B (zh) * 2008-08-08 2011-09-21 鲁南制药集团股份有限公司 单硝酸异山梨酯渗透泵型控释制剂及其制备方法
CN101766581B (zh) * 2008-12-30 2012-08-15 北京科信必成医药科技发展有限公司 一种群孔释放的盐酸地尔硫卓择时控释片及其制备方法
BRPI0925100A2 (pt) * 2009-06-02 2016-07-19 Dow Global Technologies Llc forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica
CN101953822B (zh) * 2010-07-30 2012-05-30 合肥立方制药股份有限公司 一种盐酸文拉法辛控释片及其制备方法
CN102670553A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 盐酸文拉法辛渗透泵控释片
CN102349879B (zh) * 2011-10-14 2016-07-13 北京科信必成医药科技发展有限公司 一种去甲文拉法辛控释片及其制备方法
CN102349878B (zh) * 2011-10-14 2016-05-11 北京科信必成医药科技发展有限公司 一种微孔释放渗透泵控释片及其制备方法
WO2014184662A2 (en) 2013-03-14 2014-11-20 Redhill Biopharma Ltd. Antiemetic extended release solid dosage forms
CN104127401A (zh) * 2013-08-28 2014-11-05 山东绿叶制药有限公司 含有去甲基文拉法辛苯甲酸酯类化合物的渗透泵控释组合物
US9675588B2 (en) 2014-03-11 2017-06-13 Redhill Biopharma Ltd. Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms
US10172800B2 (en) 2015-02-20 2019-01-08 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form with enhanced pharmacokinetics
US10987328B2 (en) 2015-02-20 2021-04-27 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form
US10300032B2 (en) 2015-02-20 2019-05-28 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form
US9579289B2 (en) 2015-02-20 2017-02-28 Osmotica Kereskedelmi Es Szolgaltato Kft Controlled release dosage form
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate
CN112999179B (zh) * 2019-12-20 2024-02-23 成都康弘药业集团股份有限公司 一种含盐酸文拉法辛的药物组合物
CN117338741B (zh) * 2023-09-20 2024-05-24 江苏神华药业有限公司 一种治疗心律失常的单室渗透泵片及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
IL128043A (en) * 1997-05-30 2004-08-31 Osmotica Corp Multi-layered osmotic device for controlled delivery of active agents
US8293799B2 (en) * 2003-12-29 2012-10-23 Osmotica Keresleedelmo és Szolgáltató KFT Osmotic device containing a venlafaxine salt and a salt having an ion in common
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
CN100463676C (zh) * 2004-11-11 2009-02-25 成都康弘药业集团股份有限公司 一种盐酸文拉法辛控释片制剂及其制备方法
CN100584319C (zh) * 2006-10-16 2010-01-27 北京科信必成医药科技发展有限公司 群孔释放渗透泵控释片及其制备方法

Also Published As

Publication number Publication date
EP2085078B1 (en) 2013-11-20
CN100584319C (zh) 2010-01-27
EP2679220B1 (en) 2019-08-21
PL2679220T3 (pl) 2020-04-30
CN1923184A (zh) 2007-03-07
US20100291208A1 (en) 2010-11-18
ES2446267T3 (es) 2014-03-06
US8703193B2 (en) 2014-04-22
DK2085078T3 (en) 2014-02-17
WO2008052417A1 (fr) 2008-05-08
PL2085078T3 (pl) 2014-05-30
ES2755716T3 (es) 2020-04-23
EP2085078A4 (en) 2011-10-05
EP2679220A1 (en) 2014-01-01
DK2679220T3 (da) 2019-11-18
EP2085078A1 (en) 2009-08-05

Similar Documents

Publication Publication Date Title
HK1136962A1 (en) Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof
HK1117164A1 (en) Dicyclic azaalkane derivatives, preparing method and pharmaceutical use thereof
EP2116372A4 (en) MULTILAYER POROUS MEMBRANE AND METHOD OF MANUFACTURING THEREOF
EP2329810A4 (en) DRUG DISPENSING SYSTEM WITH MAGNETIC RETENTION, MANUFACTURING PROCESS AND APPLICATION
ZA200808365B (en) Dicyclooctane derivates, preparation processes and pharmaceutical uses thereof
IL198289A (en) Processed dihydropyrazolones, processes for their preparation, medicinal preparations containing them and their use in the preparation of medicinal preparations
IL208832A (en) 3-Aminocarbazole Compound, Pharmaceutical Preparations Containing Them, Methods of Preparation and Use for Drug Preparation
EP1972251A4 (en) CAPSULE TYPE CONTAINER AND ADMINISTRATION METHOD USING THE SAME
EP1807018A4 (en) SYSTEM FOR CONTROLLED IN-SITU ADMINISTRATION OF MEDICINAL PRODUCTS
EP1731183A4 (en) SOLID PHARMACEUTICAL PREPARATION FOR DIALYSIS
IL193019A0 (en) Drug delivery systems containing weakly basic drugs and organic acids and methods for the preparation thereof
IL205665A (en) The history of terroiril, the process of preparing them, the drugs containing them and their use in the preparation of drugs
EP1832298A4 (en) MATRIX-TYPE-CONTROLLED RELEASE PREPARATION COMPRISING A BASIC SUBSTANCE OR SALT THEREOF AND PROCESS FOR PRODUCTION THEREOF
GB2488731B (en) Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof
EP2157093A4 (en) HETEROCYCLIC PYRROLO-NITROGEN-DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL USE
IL218121A0 (en) Drug delivery system and method of method of manufacturing thereof
SI1957073T1 (sl) Medicinsko zdravilo
IL202179A0 (en) Pharmaceutical solid preparation comprising benzazepines and production method thereof
EP2199696A4 (en) TYPE OF ACTIVE THERMOREGULATION SYSTEM WITHOUT MOTION PRODUCTION AND METHOD THEREOF
EP2478919A4 (en) CONTROLLED RELEASE TABLET INCORPORATING AN OSMOTIC PUMP AND METHOD FOR PREPARING THE SAME
IL187335A0 (en) Capsule imaging devices, systems and methods for in vivo imaging applications
EP2025672A4 (en) 7-ELEMENT HETEROCYCLIC RING, PROCESS FOR PRODUCTION THEREOF AND PHARMACEUTICAL USES THEREOF
EP2201011A4 (en) NEW COMPOUNDS WITH INDAZOUS OUTS, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
EP2184277A4 (en) ARYLPYRIMIDINE DERIVATIVES, METHODS OF PREPARATION AND PHARMACEUTICAL USES OF THE DERIVATIVES
EP1976490A4 (en) EXTENDED RELEASE TABLET CONTAINING ZALTOPROFEN AND PROCESS FOR PREPARING SAID TABLET